Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
Bormioli Pharma, an international leader in the production of pharmaceutical packaging and medical devices, today announced robust growth in its North American business in 2022, with sales increasing more than…